17th Oct 2007 11:48
Dechra Pharmaceuticals PLC17 October 2007 Issued by Citigate Dewe Rogerson Limited, BirminghamDate: 17 October 2007 Dechra(R) Pharmaceuticals PLC (the "Company" or the "Group") Results of Annual General Meeting ("AGM") Dechra Pharmaceuticals PLC announces that all resolutions proposed at its AGMheld today were duly passed by shareholders in attendance on a show of hands. Copies of the following: • Ordinary resolution relating to the renewal of the authority for the directors to allot new shares; • Special resolution relating to the renewal of the authority for the directors to disapply pre-emption rights; and • Special resolution relating to the renewal of the authority for the Company to purchase its own shares; being resolutions (other than resolutions concerning ordinary business) passedby the Company at its AGM on 17 October 2007, have been submitted to the UKListing Authority and will shortly be available for publication at the UKListing Authority's Document Viewing Facility which is situated at : Financial Services Authority 25 The North Colonnade Canary Wharf London E14 5HS Tel : 020 7066 1000 Details of the proxy voting instructions lodged prior to the AGM are set outbelow: Resolution For Against Discretionary Abstained(No. as noted on proxy form) Resolution 1: 31,421,248 0 21,039 0To receive and consider report and accounts Resolution 2: 30,173,053 8,966 21,039 1,239,229To receive and approve the Directors Remuneration Report Resolution 3: 31,421,248 0 21,039 0To declare a final dividend(to be paid on 23 November 2007 to all members on theregister at close of business on 26 October 2007) Resolution 4: 27,560,643 1,926,966 22,824 1,931,854To re-elect Michael Redmond Resolution 5: 31,417,355 1,500 22,824 608To re-elect Edwin Torr Resolution 6: 31,277,168 134,580 23,039 7,500To re-appoint KPMG Audit plc as Auditors and to authorisethe directors to fix their remuneration Resolution 7: 31,410,587 3,318 23,039 5,343To grant authority to allot equity securities Resolution 8: 31,406,407 3,110 29,307 3,463To renew authority for pre-emptive allotment of equitysecurities Resolution 9: 31,402,753 5,081 27,162 7,291To grant authority to the Company to purchase ordinaryshares Enquiries:Zoe Bamford, Company SecretaryDechra Pharmaceuticals PLCTel: +44 (0) 1782 771100 Trade Marks appear throughout this release in italics. Dechra and the Dechra 'D' logo are registered Trade Marks of Dechra Pharmaceuticals PLC. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
DPH.L